跳至主要内容
临床试验/ACTRN12621001511820
ACTRN12621001511820已完成2 期

A randomised, double blinded, placebo controlled trial assessing the effect of bovine lactoferrin supplementation on immune cell profiles, ex-vivo response to respiratory virus Infection and systemic inflammation in healthy, older adults.

The University of Newcastle0 个研究点目标入组 103 人开始时间: 2021年11月5日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
103

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
50 Years 至 o limit(—)
性别
All

入选标准

  • Males and females aged 50 years of age or older
  • Non-smokers (ceased smoking more than 6 months prior)

排除标准

  • Cow’s milk allergy (self-reported)
  • Dietary or nutritional supplement use within the previous 4 weeks. If appropriate to do so, supplements that are not being taken for a health condition may be washed out for 2-4 weeks before commencing the trial
  • Current smokers (smoked within previous 6 months)
  • Maintenance use of systemic corticosteroid, immunosuppressive or antibiotic drugs
  • Unstable cardiac, renal, hypertensive, pulmonary, endocrine, immunologic, neurologic disorders
  • Acute or terminal illness, human immunodeficiency virus (HIV) or active cancer
  • Any other medical condition which may interfere with the participant’s ability to participate in the intervention.

研究者

相似试验